Program Faculty & Research

Pharmaceutical Sciences Faculty | Affiliate Faculty | Emeritus Faculty

Pharmaceutical Sciences Faculty
Arash Bashirullah
Arash Bashirullah, Associate Professor (Drug Action)| Lab Website

Research Interests: Intercellular communication: uncovering mechanisms that coordinate the development of multicellular organisms. 

Tim Bugni
Tim Bugni, Professor (Drug Discovery)| Bugni Lab Website

Research Interests: Marine natural products chemistry; antibiotic drug discovery; structure determination of novel natural products using NMR and mass spectrometry; and metabolomics studies of marine invertebrate associated microorganisms.

Ron Burnette
Ron Burnette, Professor and Chair (Drug Delivery)

Research Interests: Developing a molecular level mechanistic understanding of the delivery and stability of drugs by physical chemical characterization of guest-host interactions using computational chemistry and NMR as well as studies in pharmacokinetics and pharmacodynamics.

Margaret Clagett-Dame
Margaret Clagett-Dame, Professor (Drug Action)

Research Interests: Therapeutic applications of vitamin A and vitamin D analogs; retinoids in embryonic and nervous system development.

Lara Collier
Lara Collier, Associate Professor (Drug Action)

Research Interests: Genetic and pharmacologic approaches to study disease development and treatment, focusing on cancer and central nervous system diseases.

Jun Dai
Jun Dai, Assistant Professor (Drug Action)

Transcriptional networks that control keratinocyte growth/differentiation and epidermal barrier function and therapeutic targets in the treatment of skin diseases.

Melgardt de Villiers
Melgardt de Villiers, Professor (CHS) (Drug Delivery)

Research Interests: Teaching pharmaceutics and developing novel nanometer and micrometer sized drug delivery systems.

Jennifer Golden
Jennifer Golden, Assistant Professor (Drug Discovery)| Golden Lab Website

Research Interests: Synthetic methodology, medicinal chemistry and drug discovery.  Optimization of structure-activity and structure-property relationships.  Exploratory pharmacological mining of novel chemical scaffolds.  Emphasis on development of anticancer and anti-infective agents.

Warren Heideman
Warren Heideman, Professor (Drug Action)

Research Interests: Understanding the molecular mechanisms that regulate the cellular transition from quiescence to growth; identifying critical mechanisms regulating vertebrate development that are disrupted by environmental contaminants; evaluating the impact of nanomaterials on early development; creating strategies for the fermentative production of biofuels.

Seungpyo Hong
Seungpyo Hong, Professor (Drug Delivery)| Hong Lab website

Research Interests: Biomimetic nanotechnology; Nanomaterial-cell interactions; Targeted drug delivery; Novel designs and engineering of nanocarriers; Cancer diagnostics/prognostics; Surface engineering.

Richard Hsung
Richard Hsung, Professor (Drug Discovery)| Lab Group Page

Research Interests: Developing novel and practical synthetic methods for drug discovery; total syntheses of complex natural products with biological relevance; syntheses of de novo protease inhibitors for drug designs and asymmetric catalysis.

Jiaoyang Jiang
Jiaoyang Jiang, Assistant Professor (Drug Discovery)| Jiang Lab website

Research Interests: Study the mechanism and function of protein post-translational modifications using a variety of interdisciplinary approaches, such as chemical biology, enzymology, biochemistry, mass spectrometry, X-ray crystallography, cell biology, and genetics.

Jeffrey Johnson
Jeffrey Johnson, Professor (Drug Action)| Lab Webpage

Research Interests: Signal transduction, transcriptional control of neuroprotective genes and neurotoxicity in Parkinson’s, Alzheimer’s, Huntington’s and Neuromuscular disease.

Jason Kwan
Jason Kwan, Assistant Professor (Drug Discovery)| Lab Website

Research Interests: The role of uncultured symbionts in natural product biosynthesis within marine invertebrates; marine natural product chemistry; drug discovery; next-generation sequencing; metagenomics; bioinformatics; biosynthesis.

Glen Kwon
Glen Kwon, Professor (Drug Delivery)| Kwon Lab Website

Research Interests: Drug delivery; drug targeting; pharmaceutical nanotechnology; polymeric micelles; polymeric drug conjugates; PEGylation.

 

Charles Lauhon
Charles Lauhon, Associate Professor and Vice Chair (Drug Discovery)

Research Interests: Bioorganic chemistry of RNA modifying enzymes; bioorganic chemistry of RNA; nucleotide based drug design.

Lingjun Li
Lingjun Li, Professor (Drug Action)(Drug Discovery)| Li Lab Website

Research Interests: Analytical neurochemistry; neuropeptides; proteomics and peptidomics; glycomics and glycoproteomics; biomarker discovery in neurodegenerative diseases; quantitative system biology; metabolomics; microseparations; imaging mass spectrometry and its application to drug delivery and biodistribution; biological mass spectrometry.

Paul Marker
Paul Marker, Professor (Drug Action)| Marker Lab Website

Research Interests: Molecular basis of prostate development; prostate cancer progression; benign prostatic hyperplasia; roles of cell-cell signaling pathways and the use of mouse genetics to discover novel pathways that underlie prostatic diseases.

Sandro Mecozzi
Sandro Mecozzi, Professor (Drug Delivery)(Drug Discovery)

Research Interests: Di- and tri-block copolymers in drug delivery and imaging; 19F-MRI; nanotechnologies in cancer therapy; immunotherapies; molecular recognition of RNA.

Jason Peters
Jason Peters, Assistant Professor (Drug Action)

Antibiotic-resistant bacterial pathogens are responsible for the deaths of thousands of people in the United States each year. I am developing strategies to identify new weaknesses in these pathogens by probing genes that are central to bacterial life on a massive scale. The knowledge I gain from my studies will be directly relevant for controlling pathogens and determining how antibiotics work.

Jeanette Roberts
Jeanette Roberts, Professor

Herbal medicines and other dietary supplements. Antioxidants in cancer chemoprevention. Chemoprotection and chemoprevention by manipulating cellular sulfur and selenium levels.  Global health.  Science in policy.  (No longer accepting graduate students or postdocs).

Steven Swanson
Steven Swanson, Professor and Dean (Drug Action)(Drug Discovery)

Research Interests: Molecular and cellular based screens for the discovery of novel anticancer agents from natural substances; elucidation of molecular mechanisms of active compounds; mouse-based studies of preclinical efficiency.

Weiping Tang
Weiping Tang, Professor (Drug Discovery)| Tang Lab Website

Medicinal chemistry, carbohydrate synthesis, synthetic methodology, and chemical biology.  We use a variety of chemical and biological tools for drug discovery.  We are currently interested in studying small molecules that can selectively modulate the stability of disease-causing proteins.  

Michael Taylor
Michael Taylor, Assistant Professor (Drug Action)(Drug Delivery)

Research Interests: Development and function of the blood-brain barrier; regulation of major histocompatibilty complex; modulation of neuroinflammation.

 

Robert Thorne
Robert Thorne, Assistant Professor (Drug Delivery)| Thorne Lab Website

Research Interests: Mechanisms and strategies for the central nervous system delivery and distribution of biologics (peptides, proteins, siRNA, nanoparticles, and viral gene therapy vectors).  Focus on:  antibody-based drugs and adeno-associated virus vectors for gene therapy; intraparenchymal, intrathecal and intranasal routes of administration.

Lian Yu
Lian Yu, Professor (Drug Delivery)| Yu Lab Website

Research Interests: Pharmaceutical materials science; solid-state chemistry; amorphous pharmaceuticals; molecular glasses; crystallization; polymorphism; surface mobility; polymeric crystallization inhibitors.

 

^ Back to top

Affiliate Faculty
Ralph Albrecht
Ralph Albrecht, Affiliate Professor, School of Pharmacy; Professor, Departments of Animal Sciences & Pediatrics (Drug Action)(Drug Delivery)

Research Interests: Use of inductively heated, antibody targeted, core-shell nanoparticles for selective removal of targeted cells in vitro and in vivo. Development of high resolution nanoparticle labeling systems for correlative microscopy.

Weibo Cai
Weibo Cai, Affiliate Professor, School of Pharmacy; Professor of Radiology, School of Medicine and Public Health (Drug Delivery)

Biomedical nanotechnology; molecular imaging (mostly positron emission tomography and multimodal); image-guided drug delivery; theranostic translational research; tumor targeting; cancer diagnosis/therapy; imaging of cardiovascular diseases and diabetes.

Adnan Elfarra
Adnan Elfarra, Affiliate Professor, School of Pharmacy; Professor of Toxicology, Dept Comparative Biosciences, Vet Med School (Drug Action)

Research Interests: Bioactivation and detoxification of drugs, industrial chemicals, and environmental toxicants; biochemical basis for target organ selectivity; and biomarkers of toxicant exposure.

Aparna Lakkaraju
Aparna Lakkaraju, Affiliate Associate Professor, School of Pharmacy; Associate Professor, Ophthalmology & Visual Sciences, SMPH (Drug Action)

Research Interests: Identification of mechanisms underlying retinal degenerations using state-of-the-art live-cell imaging, mouse models, and novel genetic tools.  Emphasis on developing novel therapeutics to prevent vision loss.

William Ricke
William Ricke, Affiliate Professor, School of Pharmacy; UW-Medical Foundation Professor of Urologic Research (Drug Action)

Research Interests: Understanding the molecular mechanisms involved with hormone therapy in the prevention and treatment of urologic cancers and benign diseases. Focus areas include: translational research, steroids and small molecules, stromal-epithelial interactions, endocrine disrupting chemicals, mouse models of disease progression.

Lauren Trepanier
Lauren Trepanier, Affiliate Professor, School of Pharmacy; Professor, Dept of Medical Sciences, School of Veterinary Med (Drug Action)

Research Interests: Pharmacogenetics of xenobiotic toxicity, including both therapeutic drugs and environmental carcinogens.  Mechanisms of familial and acquired risk for sulfamethoxazole drug hypersensitivity (“sulfa allergy”).  Genetic variability in phase II detoxification pathways (especially GSTs and cytochrome b5 reductase) and cancer risk in both humans and dogs.

Chad Vezina
Chad Vezina, Affiliate Associate Professor, School of Pharmacy; Associate Professor of Toxicology, Comparative Biosciences, Vet Med (Drug Action)

Research Interests: Molecular basis of prostate and urinary tract development, physiology, and toxicology.

Jamey Weichert
Jamey Weichert, Affiliate Associate Professor, School of Pharmacy; Associate Professor, Department of Radiology (Drug Delivery)(Drug Discovery)

Research Interests:  Design and development of tumor targeted molecular agents for imaging, radiotherapy, and immunotherapy oncology applications. 

^ Back to top

Other Faculty Trainers
Warren Rose
Warren Rose, Associate Professor (CHS); Associate Professor of Pharmacy and Medicine (Drug Discovery)

Research Interests: • Antimicrobial resistance and pharmacodynamics  • Antimicrobial effects on host-pathogen interactions

Cody Wenthur
Cody Wenthur, Assistant Professor; (Drug Action)

Elucidating how neurochemical systems interact to support maladaptive learning and synaptic plasticity; Development of novel bioconjugates to probe the effects of psychoactive substances; Identifying biomarkers of ongoing drug abuse; Assessing barriers to implementation of novel addiction treatment paradigms.

^ Back to top